Jefferies Group LLC Celcuity Inc. Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$17.35 - $24.87 $3.37 Million - $4.83 Million
-194,194 Closed
0 $0
Q2 2021

Sep 21, 2023
BUY
$14.25 - $30.93 $2.77 Million - $6.01 Million
194,194 New
194,194 $4.66 Million
Q2 2021

Aug 16, 2021
BUY
$14.25 - $30.93 $2.77 Million - $6.01 Million
194,194 New
194,194 $4.66 Million

Others Institutions Holding CELC

# of Institutions
107
Shares Held
30.4M
Call Options Held
30.8K
Put Options Held
152K
View Full List

About Celcuity Inc.

CELC Quotes by TradingView
  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $172M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email